» Articles » PMID: 17940943

Marburg Hemorrhagic Fever in Durba and Watsa, Democratic Republic of the Congo: Clinical Documentation, Features of Illness, and Treatment

Abstract

The objective of the present study was to describe day of onset and duration of symptoms of Marburg hemorrhagic fever (MHF), to summarize the treatments applied, and to assess the quality of clinical documentation. Surveillance and clinical records of 77 patients with MHF cases were reviewed. Initial symptoms included fever, headache, general pain, nausea, vomiting, and anorexia (median day of onset, day 1-2), followed by hemorrhagic manifestations (day 5-8+), and terminal symptoms included confusion, agitation, coma, anuria, and shock. Treatment in isolation wards was acceptable, but the quality of clinical documentation was unsatisfactory. Improved clinical documentation is necessary for a basic evaluation of supportive treatment.

Citing Articles

Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing.

Zumbrun E, Garvey C, Wells J, Lynn G, Van Tongeren S, Steffens J Viruses. 2023; 15(12).

PMID: 38140576 PMC: 10748006. DOI: 10.3390/v15122335.


Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges.

Srivastava S, Sharma D, Kumar S, Sharma A, Rijal R, Asija A Front Microbiol. 2023; 14:1239079.

PMID: 37771708 PMC: 10526840. DOI: 10.3389/fmicb.2023.1239079.


Marburg virus disease: the paradox of Nigeria's preparedness and priority effects in co-epidemics.

Reuben R, Abunike S Bull Natl Res Cent. 2023; 47(1):10.

PMID: 36721499 PMC: 9880916. DOI: 10.1186/s42269-023-00987-1.


Marburg virus outbreak in Ghana: An impending crisis.

Wellington J, Nur A, Nicholas A, Uwishema O, Chaito H, Awosiku O Ann Med Surg (Lond). 2022; 81:104377.

PMID: 36051815 PMC: 9424924. DOI: 10.1016/j.amsu.2022.104377.


Sagacious Perceptive on Marburg Virus Foregrounding the Recent Findings: A Critical Review.

Baby B, Rajendran R, Nair M, Raghavan R Infect Disord Drug Targets. 2022; 22(8):13-18.

PMID: 35538802 DOI: 10.2174/1871526522666220510103618.